Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 34 Carcinoma, Hepatocellular 33 Carcinoma, Non-Small-Cell Lung 23 Colorectal Neoplasms 16 Esophageal Squamous Cell Carcinoma 12 Lung Neoplasms 9 Rectal Neoplasms 8 Nasopharyngeal Carcinoma 8 Esophageal Neoplasms 6 Cholangiocarcinoma 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasm Metastasis 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Pancreatic Neoplasms 4 Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Renal Cell 4 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Extranodal NK-T-Cell 3 Carcinoma 3 Breast Neoplasms 3 Spinocerebellar Degenerations 2 Sarcoma 2 Recurrence 2 Nonsquamous Non-Small Cell Lung Cancer 2 Neuroendocrine Tumors 2 Lymphoma, T-Cell, Peripheral 2 Locally Advanced Rectal Cancer 2

Interventions

lenvatinib 3 Gemcitabine 3 tislelizumab 2 pembrolizumab 2 Cisplatin 2 toripalimab 1 titanium silicide 1 theasinensin A 1 surufatinib 1 sitravatinib 1 sintilimab 1 durvalumab 1 S 1 (combination) 1 Nivolumab 1 Folfox protocol 1 Fluorouracil 1 Cryosurgery 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Biliary Tract Cancer × sintilimab × Clear all

NCT05781074 2023-03-24

CASTLE-08

Fudan University

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡